The global siRNA Conjugates market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
RNA interference (RNAi) has revolutionized gene therapy, with small interfering RNA (siRNA) being a key player in silencing disease-causing genes. However, challenges in efficient delivery and off-target effects have limited its full therapeutic application. siRNA conjugates represent a sophisticated strategy to enhance the stability, delivery, and specificity of siRNA-based therapeutics.siRNA conjugates involve the chemical attachment of siRNA molecules to various functional groups, carriers, or ligands to improve their cellular uptake, stability, and therapeutic potential. These conjugates offer several advantages, including targeted delivery to specific tissues or cells, enhanced resistance to enzymatic degradation, and reduced off-target effects. The core strategy behind siRNA conjugation is to overcome the barriers of free siRNA, such as poor cellular uptake, rapid clearance, and undesired immune responses, thus ensuring more efficient gene silencing.
North American market for siRNA Conjugates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for siRNA Conjugates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of siRNA Conjugates include WuXi XDC, Creative Biogene, Bachem, LGC Biosearch Technologies, Sinopep, Organix, CD Formulation, Hitgen, Alnylam Pharmaceuticals,, Amerigo Scientific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for siRNA Conjugates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding siRNA Conjugates.
The siRNA Conjugates market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global siRNA Conjugates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the siRNA Conjugates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
WuXi XDC
Creative Biogene
Bachem
LGC Biosearch Technologies
Sinopep
Organix
CD Formulation
Hitgen
Alnylam Pharmaceuticals,
Amerigo Scientific
BOCSCI Inc.
Creative Biolabs
Bio-Synthesis Inc
Creative Peptide
GenSript
Suzhou Biosyntech
by Type
Antibody-siRNA Conjugates
GalNAc-siRNA Conjugates
Peptide-siRNA Conjugates
Other
by Application
Gene Therapy
Drug Delivery
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of siRNA Conjugates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of siRNA Conjugates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 siRNA Conjugates 麻豆原创 Overview
1.1 Product Definition
1.2 siRNA Conjugates by Type
1.2.1 Global siRNA Conjugates 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Antibody-siRNA Conjugates
1.2.3 GalNAc-siRNA Conjugates
1.2.4 Peptide-siRNA Conjugates
1.2.5 Other
1.3 siRNA Conjugates by Application
1.3.1 Global siRNA Conjugates 麻豆原创 Value by Application (2024-2030)
1.3.2 Gene Therapy
1.3.3 Drug Delivery
1.3.4 Other
1.4 Global siRNA Conjugates 麻豆原创 Size Estimates and Forecasts
1.4.1 Global siRNA Conjugates Revenue 2019-2030
1.4.2 Global siRNA Conjugates Sales 2019-2030
1.4.3 Global siRNA Conjugates 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 siRNA Conjugates 麻豆原创 Competition by Manufacturers
2.1 Global siRNA Conjugates Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global siRNA Conjugates Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global siRNA Conjugates Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of siRNA Conjugates, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of siRNA Conjugates, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of siRNA Conjugates, Product Type & Application
2.7 Global Key Manufacturers of siRNA Conjugates, Date of Enter into This Industry
2.8 Global siRNA Conjugates 麻豆原创 Competitive Situation and Trends
2.8.1 Global siRNA Conjugates 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest siRNA Conjugates Players 麻豆原创 Share by Revenue
2.8.3 Global siRNA Conjugates 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global siRNA Conjugates 麻豆原创 Scenario by Region
3.1 Global siRNA Conjugates 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global siRNA Conjugates Sales by Region: 2019-2030
3.2.1 Global siRNA Conjugates Sales by Region: 2019-2024
3.2.2 Global siRNA Conjugates Sales by Region: 2025-2030
3.3 Global siRNA Conjugates Revenue by Region: 2019-2030
3.3.1 Global siRNA Conjugates Revenue by Region: 2019-2024
3.3.2 Global siRNA Conjugates Revenue by Region: 2025-2030
3.4 North America siRNA Conjugates 麻豆原创 Facts & Figures by Country
3.4.1 North America siRNA Conjugates 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America siRNA Conjugates Sales by Country (2019-2030)
3.4.3 North America siRNA Conjugates Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe siRNA Conjugates 麻豆原创 Facts & Figures by Country
3.5.1 Europe siRNA Conjugates 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe siRNA Conjugates Sales by Country (2019-2030)
3.5.3 Europe siRNA Conjugates Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific siRNA Conjugates 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific siRNA Conjugates 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific siRNA Conjugates Sales by Region (2019-2030)
3.6.3 Asia Pacific siRNA Conjugates Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America siRNA Conjugates 麻豆原创 Facts & Figures by Country
3.7.1 Latin America siRNA Conjugates 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America siRNA Conjugates Sales by Country (2019-2030)
3.7.3 Latin America siRNA Conjugates Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa siRNA Conjugates 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa siRNA Conjugates 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa siRNA Conjugates Sales by Country (2019-2030)
3.8.3 Middle East and Africa siRNA Conjugates Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global siRNA Conjugates Sales by Type (2019-2030)
4.1.1 Global siRNA Conjugates Sales by Type (2019-2024)
4.1.2 Global siRNA Conjugates Sales by Type (2025-2030)
4.1.3 Global siRNA Conjugates Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global siRNA Conjugates Revenue by Type (2019-2030)
4.2.1 Global siRNA Conjugates Revenue by Type (2019-2024)
4.2.2 Global siRNA Conjugates Revenue by Type (2025-2030)
4.2.3 Global siRNA Conjugates Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global siRNA Conjugates Price by Type (2019-2030)
5 Segment by Application
5.1 Global siRNA Conjugates Sales by Application (2019-2030)
5.1.1 Global siRNA Conjugates Sales by Application (2019-2024)
5.1.2 Global siRNA Conjugates Sales by Application (2025-2030)
5.1.3 Global siRNA Conjugates Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global siRNA Conjugates Revenue by Application (2019-2030)
5.2.1 Global siRNA Conjugates Revenue by Application (2019-2024)
5.2.2 Global siRNA Conjugates Revenue by Application (2025-2030)
5.2.3 Global siRNA Conjugates Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global siRNA Conjugates Price by Application (2019-2030)
6 Key Companies Profiled
6.1 WuXi XDC
6.1.1 WuXi XDC Company Information
6.1.2 WuXi XDC Description and Business Overview
6.1.3 WuXi XDC siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.1.4 WuXi XDC siRNA Conjugates Product Portfolio
6.1.5 WuXi XDC Recent Developments/Updates
6.2 Creative Biogene
6.2.1 Creative Biogene Company Information
6.2.2 Creative Biogene Description and Business Overview
6.2.3 Creative Biogene siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Creative Biogene siRNA Conjugates Product Portfolio
6.2.5 Creative Biogene Recent Developments/Updates
6.3 Bachem
6.3.1 Bachem Company Information
6.3.2 Bachem Description and Business Overview
6.3.3 Bachem siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bachem siRNA Conjugates Product Portfolio
6.3.5 Bachem Recent Developments/Updates
6.4 LGC Biosearch Technologies
6.4.1 LGC Biosearch Technologies Company Information
6.4.2 LGC Biosearch Technologies Description and Business Overview
6.4.3 LGC Biosearch Technologies siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LGC Biosearch Technologies siRNA Conjugates Product Portfolio
6.4.5 LGC Biosearch Technologies Recent Developments/Updates
6.5 Sinopep
6.5.1 Sinopep Company Information
6.5.2 Sinopep Description and Business Overview
6.5.3 Sinopep siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sinopep siRNA Conjugates Product Portfolio
6.5.5 Sinopep Recent Developments/Updates
6.6 Organix
6.6.1 Organix Company Information
6.6.2 Organix Description and Business Overview
6.6.3 Organix siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Organix siRNA Conjugates Product Portfolio
6.6.5 Organix Recent Developments/Updates
6.7 CD Formulation
6.7.1 CD Formulation Company Information
6.7.2 CD Formulation Description and Business Overview
6.7.3 CD Formulation siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.7.4 CD Formulation siRNA Conjugates Product Portfolio
6.7.5 CD Formulation Recent Developments/Updates
6.8 Hitgen
6.8.1 Hitgen Company Information
6.8.2 Hitgen Description and Business Overview
6.8.3 Hitgen siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hitgen siRNA Conjugates Product Portfolio
6.8.5 Hitgen Recent Developments/Updates
6.9 Alnylam Pharmaceuticals,
6.9.1 Alnylam Pharmaceuticals, Company Information
6.9.2 Alnylam Pharmaceuticals, Description and Business Overview
6.9.3 Alnylam Pharmaceuticals, siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Alnylam Pharmaceuticals, siRNA Conjugates Product Portfolio
6.9.5 Alnylam Pharmaceuticals, Recent Developments/Updates
6.10 Amerigo Scientific
6.10.1 Amerigo Scientific Company Information
6.10.2 Amerigo Scientific Description and Business Overview
6.10.3 Amerigo Scientific siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Amerigo Scientific siRNA Conjugates Product Portfolio
6.10.5 Amerigo Scientific Recent Developments/Updates
6.11 BOCSCI Inc.
6.11.1 BOCSCI Inc. Company Information
6.11.2 BOCSCI Inc. Description and Business Overview
6.11.3 BOCSCI Inc. siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.11.4 BOCSCI Inc. siRNA Conjugates Product Portfolio
6.11.5 BOCSCI Inc. Recent Developments/Updates
6.12 Creative Biolabs
6.12.1 Creative Biolabs Company Information
6.12.2 Creative Biolabs Description and Business Overview
6.12.3 Creative Biolabs siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Creative Biolabs siRNA Conjugates Product Portfolio
6.12.5 Creative Biolabs Recent Developments/Updates
6.13 Bio-Synthesis Inc
6.13.1 Bio-Synthesis Inc Company Information
6.13.2 Bio-Synthesis Inc Description and Business Overview
6.13.3 Bio-Synthesis Inc siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Bio-Synthesis Inc siRNA Conjugates Product Portfolio
6.13.5 Bio-Synthesis Inc Recent Developments/Updates
6.14 Creative Peptide
6.14.1 Creative Peptide Company Information
6.14.2 Creative Peptide Description and Business Overview
6.14.3 Creative Peptide siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Creative Peptide siRNA Conjugates Product Portfolio
6.14.5 Creative Peptide Recent Developments/Updates
6.15 GenSript
6.15.1 GenSript Company Information
6.15.2 GenSript Description and Business Overview
6.15.3 GenSript siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.15.4 GenSript siRNA Conjugates Product Portfolio
6.15.5 GenSript Recent Developments/Updates
6.16 Suzhou Biosyntech
6.16.1 Suzhou Biosyntech Company Information
6.16.2 Suzhou Biosyntech Description and Business Overview
6.16.3 Suzhou Biosyntech siRNA Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Suzhou Biosyntech siRNA Conjugates Product Portfolio
6.16.5 Suzhou Biosyntech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 siRNA Conjugates Industry Chain Analysis
7.2 siRNA Conjugates Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 siRNA Conjugates Production Mode & Process
7.4 siRNA Conjugates Sales and 麻豆原创ing
7.4.1 siRNA Conjugates Sales Channels
7.4.2 siRNA Conjugates Distributors
7.5 siRNA Conjugates Customers
8 siRNA Conjugates 麻豆原创 Dynamics
8.1 siRNA Conjugates Industry Trends
8.2 siRNA Conjugates 麻豆原创 Drivers
8.3 siRNA Conjugates 麻豆原创 Challenges
8.4 siRNA Conjugates 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
WuXi XDC
Creative Biogene
Bachem
LGC Biosearch Technologies
Sinopep
Organix
CD Formulation
Hitgen
Alnylam Pharmaceuticals,
Amerigo Scientific
BOCSCI Inc.
Creative Biolabs
Bio-Synthesis Inc
Creative Peptide
GenSript
Suzhou Biosyntech
听
听
*If Applicable.
